WallStreetZenWallStreetZen

NASDAQ: OPGN
Opgen Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for OPGN

Based on 1 analyst offering 12 month price targets for Opgen Inc.
Min Forecast
$3.00+675.19%
Avg Forecast
$3.00+675.19%
Max Forecast
$3.00+675.19%

Should I buy or sell OPGN stock?

Based on 1 analyst offering ratings for Opgen Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OPGN stock forecasts and price targets.

OPGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 5%
96
BuyMaintains$3.00+675.19%2022-05-13

1 of 1

Forecast return on equity

Is OPGN forecast to generate an efficient return?
Company
-75.95%
Industry
467.97%
Market
98.76%
OPGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OPGN forecast to generate an efficient return on assets?
Company
-42.58%
Industry
9.83%
OPGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OPGN earnings per share forecast

What is OPGN's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.55
Avg 2 year Forecast
-$0.43

OPGN revenue forecast

What is OPGN's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$5.2M+27.05%
Avg 2 year Forecast
$8.0M+93.97%
OPGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OPGN revenue growth forecast

How is OPGN forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
27.05%
Industry
-0.3%
Market
12.8%
OPGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OPGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OPGN vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
OPGN$0.39$3.00+675.19%Buy
ISPC$2.06$12.13+488.59%Strong Buy
NDRA$0.31$5.00+1,518.12%Buy
PRPO$0.78$4.00+412.82%Strong Buy
ONVO$1.95N/AN/A

Opgen Stock Forecast FAQ

Is Opgen Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: OPGN) stock is to Buy OPGN stock.

Out of 1 analyst, 0 (0%) are recommending OPGN as a Strong Buy, 1 (100%) are recommending OPGN as a Buy, 0 (0%) are recommending OPGN as a Hold, 0 (0%) are recommending OPGN as a Sell, and 0 (0%) are recommending OPGN as a Strong Sell.

If you're new to stock investing, here's how to buy Opgen stock.

What is OPGN's earnings growth forecast for 2022-2023?

(NASDAQ: OPGN) Opgen's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 25.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 46.52%.

Opgen's earnings in 2022 is -$32,679,443.On average, 2 Wall Street analysts forecast OPGN's earnings for 2022 to be -$26,579,818, with the lowest OPGN earnings forecast at -$28,512,896, and the highest OPGN earnings forecast at -$24,163,471.

In 2023, OPGN is forecast to generate -$20,780,585 in earnings, with the lowest earnings forecast at -$21,263,854 and the highest earnings forecast at -$20,297,316.

What is OPGN's revenue growth forecast for 2022-2023?

(NASDAQ: OPGN) Opgen's forecast annual revenue growth rate of 27.05% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of -0.3%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 12.8%.

Opgen's revenue in 2022 is $4,101,650.On average, 2 Wall Street analysts forecast OPGN's revenue for 2022 to be $251,831,695, with the lowest OPGN revenue forecast at $223,415,453, and the highest OPGN revenue forecast at $280,296,264.

In 2023, OPGN is forecast to generate $384,489,151 in revenue, with the lowest revenue forecast at $372,745,704 and the highest revenue forecast at $396,280,924.

What is OPGN's forecast return on assets (ROA) for 2022-2023?

(NASDAQ: OPGN) forecast ROA is -42.58%, which is lower than the forecast US Diagnostics & Research industry average of 9.83%.

What is OPGN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year OPGN price target, the average OPGN price target is $3.00, with the highest OPGN stock price forecast at $3.00 and the lowest OPGN stock price forecast at $3.00.

The Wall Street analyst predicted that Opgen's share price could reach $3.00 by May 13, 2023. The average Opgen stock price prediction forecasts a potential upside of 675.19% from the current OPGN share price of $0.39.

What is OPGN's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: OPGN) Opgen's current Earnings Per Share (EPS) is -$0.79. On average, analysts forecast that OPGN's EPS will be -$0.55 for 2022, with the lowest EPS forecast at -$0.59, and the highest EPS forecast at -$0.50. In 2023, OPGN's EPS is forecast to hit -$0.43 (min: -$0.44, max: -$0.42).

What is OPGN's forecast return on equity (ROE) for 2022-2023?

(NASDAQ: OPGN) forecast ROE is -75.95%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.